CRIP3

gene
On this page

Also known as TLP-AbA480N24.2TLP

Summary

CRIP3 (cysteine rich protein 3, HGNC:17751) is a protein-coding gene on chromosome 6p21.1, encoding Cysteine-rich protein 3 (Q6Q6R5).

Predicted to enable metal ion binding activity. Predicted to act upstream of or within T cell proliferation. Predicted to be located in cytoplasm.

Source: NCBI Gene 401262 — RefSeq curated summary.

At a glance

  • GWAS associations: 20
  • Clinical variants (ClinVar): 37 total
  • MANE Select transcript: NM_206922

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17751
Approved symbolCRIP3
Namecysteine rich protein 3
Location6p21.1
Locus typegene with protein product
StatusApproved
AliasesTLP-A, bA480N24.2, TLP
Ensembl geneENSG00000146215
Ensembl biotypeprotein_coding
Entrez401262

Gene structure

Transcript identifiers

Ensembl transcripts: 21 — 18 protein_coding, 3 retained_intron

ENST00000274990, ENST00000372569, ENST00000416431, ENST00000451294, ENST00000477866, ENST00000485819, ENST00000487744, ENST00000875330, ENST00000875331, ENST00000875332, ENST00000875333, ENST00000917954, ENST00000917955, ENST00000917956, ENST00000917957, ENST00000917958, ENST00000917959, ENST00000917960, ENST00000917961, ENST00000917962, ENST00000917963

RefSeq mRNA: 2 — MANE Select: NM_206922 NM_001366068, NM_206922

CCDS: CCDS4894

Canonical transcript exons

ENST00000372569 — 8 exons

ExonStartEnd
ENSE000009744994330831543308409
ENSE000009745014330761243307743
ENSE000009745024330644643306517
ENSE000009745034330621943306313
ENSE000014581184330547243305875
ENSE000035453604330783943307896
ENSE000035707124330606743306124
ENSE000039020204330875043308826

Expression profiles

Bgee: expression breadth ubiquitous, 165 present calls, max score 95.03.

FANTOM5 (CAGE): breadth broad, TPM avg 1.1956 / max 53.0668, expressed in 275 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
736751.0381246
736760.157490

Top tissues by expression

241 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
apex of heartUBERON:000209895.03gold quality
right testisUBERON:000453492.37gold quality
left testisUBERON:000453392.14gold quality
cerebellar hemisphereUBERON:000224590.09gold quality
right hemisphere of cerebellumUBERON:001489090.00gold quality
cerebellar cortexUBERON:000212989.98gold quality
testisUBERON:000047388.30gold quality
cerebellumUBERON:000203788.29gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.70gold quality
right lobe of liverUBERON:000111485.23gold quality
granulocyteCL:000009485.16gold quality
heart left ventricleUBERON:000208484.88gold quality
cardiac ventricleUBERON:000208284.43gold quality
nucleus accumbensUBERON:000188283.88gold quality
right frontal lobeUBERON:000281081.96gold quality
putamenUBERON:000187481.85gold quality
caudate nucleusUBERON:000187381.47gold quality
Brodmann (1909) area 9UBERON:001354081.34gold quality
amygdalaUBERON:000187681.14gold quality
spleenUBERON:000210680.55gold quality
anterior cingulate cortexUBERON:000983579.51gold quality
hypothalamusUBERON:000189879.40gold quality
dorsolateral prefrontal cortexUBERON:000983477.06gold quality
lymph nodeUBERON:000002977.05gold quality
heartUBERON:000094876.87gold quality
spermCL:000001976.36silver quality
cortical plateUBERON:000534376.34gold quality
brainUBERON:000095576.09gold quality
liverUBERON:000210775.49gold quality
C1 segment of cervical spinal cordUBERON:000646975.18gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.54

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • TLP-mediated global transcriptional repression after double-strand DNA breaks slows down DNA repair and induces apoptosis. (PMID:30890736)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriocrip3ENSDARG00000043395
mus_musculusCrip3ENSMUSG00000023968
rattus_norvegicusCrip3ENSRNOG00000018613

Paralogs (20): FHL1 (ENSG00000022267), LMO3 (ENSG00000048540), LHX5 (ENSG00000089116), ZFHX4 (ENSG00000091656), LHX2 (ENSG00000106689), LHX6 (ENSG00000106852), LHX3 (ENSG00000107187), LHX4 (ENSG00000121454), LMO2 (ENSG00000135363), ZFHX2 (ENSG00000136367), LMX1B (ENSG00000136944), ZFHX3 (ENSG00000140836), LMO4 (ENSG00000143013), LHX9 (ENSG00000143355), LHX8 (ENSG00000162624), LMX1A (ENSG00000162761), LMO1 (ENSG00000166407), CRIP2 (ENSG00000182809), CRIP1 (ENSG00000213145), LHX1 (ENSG00000273706)

Protein

Protein identifiers

Cysteine-rich protein 3Q6Q6R5 (reviewed: Q6Q6R5)

Alternative names: Chromosome 6 LIM domain only protein

All UniProt accessions (3): Q6Q6R5, H0Y7Q9, Q5T045

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Cytoplasm.

Tissue specificity. Expressed in most tissues, but not in skeletal muscle.

Isoforms (4)

UniProt IDNamesCanonical?
Q6Q6R5-11, Cyes
Q6Q6R5-22, B
Q6Q6R5-33, A
Q6Q6R5-44, D

RefSeq proteins (2): NP_001352997, NP_996805* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001781Znf_LIMDomain

Pfam: PF00412

UniProt features (9 total): splice variant 3, domain 2, sequence conflict 2, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6Q6R5-F174.810.42

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 44 (showing top): GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN, STK33_SKM_DN, ZNF322_TARGET_GENES, MIR4731_5P, GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN, MIR423_5P, MIR3184_5P, MIR6759_3P, GSE12366_NAIVE_VS_MEMORY_BCELL_UP, MIR1911_5P, BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN, GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP, HAY_BONE_MARROW_DENDRITIC_CELL, GSE17721_POLYIC_VS_CPG_16H_BMDC_UP, WRNIP1_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (2): metal ion binding (GO:0046872), protein binding (GO:0005515)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cation binding1
binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

284 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CRIP3TIRAPP58753576
CRIP3HOXD8P13378538
CRIP3MYD88P78397523
CRIP3HOXD3P31249521
CRIP3HTRA1Q92743479
CRIP3SCO1O75880467
CRIP3TGFB2P08112432
CRIP3COA6Q5JTJ3395
CRIP3H0YIS7H0YIS7393
CRIP3TMEM128Q5BJH2391
CRIP3TMEM179Q6ZVK1367
CRIP3CIMIP2AQ6J272322
CRIP3SARM1Q6SZW1317
CRIP3SH2D4BQ5SQS7316
CRIP3OR2A7Q96R45307

IntAct

1 interactions, top by confidence:

BioGRID (2): CRIP3 (Two-hybrid), FHL3 (Two-hybrid)

ESM2 similar proteins: A2YEZ6, A3BDI8, E0X9N4, O60711, O70209, O70400, O80839, P29675, P36201, P47226, P52943, P53777, Q0VFX8, Q16975, Q1LZA7, Q21192, Q24400, Q3EA33, Q3SX40, Q3SYZ8, Q3TJD7, Q4KM31, Q500W4, Q53GG5, Q5R7Y1, Q66HS7, Q679P3, Q6GLJ6, Q6INU3, Q6P7E4, Q6Q6R3, Q6Q6R5, Q6QGC0, Q7Y1W9, Q852K5, Q8BGB5, Q8H0X0, Q94JX5, Q99N69, Q9BIW5

Diamond homologs: A8DZE6, E1BKA3, F1MF74, F1QH17, F1QWK4, G3MWR8, O04193, O14014, O80839, P21291, P29675, P34416, P36201, P47875, P50238, P50460, P50461, P50462, P50463, P52943, P53410, P53777, P63254, P63255, P67966, P67967, P97314, P97315, Q04584, Q05158, Q0VFX8, Q13642, Q14192, Q16527, Q1ECF5, Q24400, Q2KI95, Q32LE9, Q3MHY1, Q4U0T9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

37 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance29
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2400 predictions. Top by Δscore:

VariantEffectΔscore
6:43299885:T:TAacceptor_gain1.0000
6:43299890:T:Aacceptor_gain1.0000
6:43299891:G:Aacceptor_gain1.0000
6:43299896:A:AGacceptor_gain1.0000
6:43299897:G:GGacceptor_gain1.0000
6:43301690:GTG:Gdonor_gain1.0000
6:43301698:G:GTdonor_gain1.0000
6:43302761:CAGGT:Cdonor_loss1.0000
6:43302762:AGGT:Adonor_loss1.0000
6:43302763:GG:Gdonor_loss1.0000
6:43302764:GTGA:Gdonor_loss1.0000
6:43302765:T:Gdonor_loss1.0000
6:43304669:A:AGacceptor_gain1.0000
6:43304670:G:GGacceptor_gain1.0000
6:43306123:TG:Tacceptor_gain1.0000
6:43306131:C:CTacceptor_gain1.0000
6:43306314:C:CCacceptor_gain1.0000
6:43307610:A:ACdonor_gain1.0000
6:43307611:C:CCdonor_gain1.0000
6:43307611:CTTTT:Cdonor_gain1.0000
6:43308514:T:TAdonor_gain1.0000
6:43299894:CCA:Cacceptor_loss0.9900
6:43299895:CA:Cacceptor_loss0.9900
6:43299896:A:Tacceptor_loss0.9900
6:43299897:G:Aacceptor_loss0.9900
6:43299897:GA:Gacceptor_gain0.9900
6:43299897:GAGC:Gacceptor_gain0.9900
6:43299897:GAGCT:Gacceptor_gain0.9900
6:43299988:T:Gdonor_gain0.9900
6:43300063:TCTGG:Tdonor_loss0.9900

AlphaMissense

1340 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:43306454:A:TV131D0.996
6:43306282:C:AW144C0.995
6:43306282:C:GW144C0.995
6:43306109:A:CY171D0.994
6:43306263:A:GC151R0.994
6:43306476:A:GC124R0.994
6:43306284:A:GW144R0.993
6:43306284:A:TW144R0.993
6:43307849:A:CF62L0.993
6:43307849:A:TF62L0.993
6:43307851:A:GF62L0.993
6:43308378:C:AW25C0.993
6:43308378:C:GW25C0.993
6:43308380:A:GW25R0.993
6:43308380:A:TW25R0.993
6:43306077:A:CF181L0.992
6:43306077:A:TF181L0.992
6:43306079:A:GF181L0.992
6:43306253:C:GC154S0.992
6:43306254:A:TC154S0.992
6:43306262:C:GC151S0.992
6:43306263:A:TC151S0.992
6:43306094:A:GC176R0.991
6:43306104:G:CC172W0.991
6:43306281:G:CH145D0.991
6:43307881:A:CY52D0.991
6:43308359:A:GC32R0.991
6:43306268:A:GL149P0.990
6:43306279:G:CH145Q0.990
6:43306279:G:TH145Q0.990

dbSNP variants (sampled 300 via entrez): RS1002130301 (6:43306679 T>C), RS1002162974 (6:43306956 C>T), RS1002798038 (6:43309582 G>A), RS1002870266 (6:43309870 A>T), RS1003203414 (6:43308489 G>A), RS1004761361 (6:43306088 C>A,T), RS1004788366 (6:43309065 C>T), RS1004827097 (6:43310330 T>C), RS1005178609 (6:43305268 A>G), RS1005250663 (6:43305540 C>A), RS1005501185 (6:43310324 C>A,T), RS1006728651 (6:43305759 A>G,T), RS1007581094 (6:43308528 G>A,C), RS1008585250 (6:43306831 G>GCCA), RS1008846918 (6:43307235 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

20 associations (top):

StudyTraitp-value
GCST004521_164Autism spectrum disorder or schizophrenia3.000000e-08
GCST005956_58Waist-to-hip ratio adjusted for BMI7.000000e-26
GCST005957_1Waist-to-hip ratio adjusted for BMI (age <50)2.000000e-14
GCST005958_2Waist-to-hip ratio adjusted for BMI (age >50)2.000000e-19
GCST005962_2Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)3.000000e-31
GCST006187_17Diastolic blood pressure (cigarette smoking interaction)1.000000e-10
GCST006188_32Systolic blood pressure (cigarette smoking interaction)8.000000e-21
GCST007096_193Pulse pressure3.000000e-06
GCST007099_135Systolic blood pressure1.000000e-09
GCST007703_139Systolic blood pressure4.000000e-10
GCST007704_105Diastolic blood pressure1.000000e-06
GCST007705_69Pulse pressure4.000000e-06
GCST007706_92Mean arterial pressure4.000000e-09
GCST007707_66Hypertension1.000000e-06
GCST008058_90Estimated glomerular filtration rate1.000000e-20
GCST008059_82Estimated glomerular filtration rate2.000000e-20
GCST008839_248Height4.000000e-08
GCST008899_1Adult hearing difficulty6.000000e-21
GCST012227_9Hip circumference adjusted for BMI2.000000e-08
GCST012442_37Age-related hearing impairment1.000000e-17

EFO canonical traits (9, from GWAS)

EFO IDTrait name
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008007age at assessment
EFO:0008343sex interaction measurement
EFO:0006336diastolic blood pressure
EFO:0006527smoking status measurement
EFO:0006335systolic blood pressure
EFO:0005763pulse pressure measurement
EFO:0006340mean arterial pressure
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases methylation, decreases expression2
Aflatoxin B1decreases expression2
propionaldehydeincreases expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
pentanalincreases expression1
di-n-butylphosphoric acidaffects expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
jinfukangaffects cotreatment, increases expression1
Resveratrolaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Leflunomidedecreases expression1
Acetaminophendecreases expression1
Cisplatinaffects cotreatment, increases expression1
Copperaffects cotreatment, decreases expression1
Diethylhexyl Phthalatedecreases expression1
N-Nitrosopyrrolidinedecreases expression1
Phenylmercuric Acetateaffects cotreatment, decreases expression1
Silicon Dioxidedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
Valproic Acidaffects expression1
Cyclosporinedecreases methylation1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hypertensive disorder, presbycusis